Study of Clinical Performance and Safety of Treatments in Degenerative Meniscopathy With Injection of Polynucleotides
A Non-randomized Multicentre Study for the Evaluation of the Clinical Performance and Safety of the Augmentation-to-surgery and Conservative Treatments for the Degenerative Meniscopathy, With Injection of Polynucleotide Gel
Sponsor: Mastelli S.r.l
Listed as NCT05322005, this NA trial focuses on Meniscus Lesion and Meniscus Tear and remains completed. Sponsored by Mastelli S.r.l, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Jun 2025 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Feb 2025 — May 2025 [monthly]
Active Not Recruiting NA
-
Nov 2024 — Feb 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Recruiting NA
-
May 2022 — Jul 2023 [monthly]
Recruiting NA
First recorded
Oct 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mastelli S.r.l
For direct contact, visit the study record on ClinicalTrials.gov .